Page last updated: 2024-09-04

febuxostat and Kidney Failure, Chronic

febuxostat has been researched along with Kidney Failure, Chronic in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's8 (80.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Agustsdottir, IMS; Dao, M; Edvardsson, VO; Indridason, OS; Knebelmann, B; Li, J; Milliner, DS; Palsson, R; Runolfsdottir, HL1
Alshahawey, M; Elsaid, TW; Sabri, NA; Shahin, SM1
Ishii, T; Oyama, K; Taguri, M; Tamura, K1
Aoki, T; Hishida, M; Maekawa, M; Morinaga, T; Tamai, H; Tomida, H1
Day, RO; Furlong, TJ; Ghosh, D; McGann, PM1
Ahn, SM; Choi, SW; Hong, S; Kim, YG; Lee, CK; Lim, DH; Oh, JS; Yoo, B1
Lee, CT; Pei, SN; Poh, XE1
El-Zawawy, H; Mandell, BF1
Schmidt, BM; Wagner, AD1
Avila-Casado, C; Franco, M; Johnson, RJ; Sánchez-Lozada, LG; Soto, V; Tapia, E; Wessale, JL; Zhao, L1

Reviews

2 review(s) available for febuxostat and Kidney Failure, Chronic

ArticleYear
Managing gout: how is it different in patients with chronic kidney disease?
    Cleveland Clinic journal of medicine, 2010, Volume: 77, Issue:12

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Comorbidity; Disease Progression; Febuxostat; Gout; Gout Suppressants; Humans; Kidney Failure, Chronic; Risk Factors; Thiazoles

2010
[Hyperuricemia, gout, pseudogout and concomitant diseases].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:48

    Topics: Allopurinol; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Chondrocalcinosis; Comorbidity; Diabetes Mellitus, Type 2; Febuxostat; Gout; Gout Suppressants; Guideline Adherence; Humans; Hypertrophy, Left Ventricular; Hyperuricemia; Interleukin 1 Receptor Antagonist Protein; Kidney Failure, Chronic; Thiazoles; Xanthine Oxidase

2011

Trials

1 trial(s) available for febuxostat and Kidney Failure, Chronic

ArticleYear
Effect of Febuxostat on the Endothelial Dysfunction in Hemodialysis Patients: A Randomized, Placebo-Controlled, Double-Blinded Study.
    American journal of nephrology, 2017, Volume: 45, Issue:5

    Topics: Administration, Oral; Adult; Alanine Transaminase; Arginine; Aspartate Aminotransferases; C-Reactive Protein; Cardiovascular Diseases; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Febuxostat; Female; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Pancytopenia; Placebos; Prospective Studies; Renal Dialysis; Risk Factors; Treatment Outcome; Uric Acid; Xanthine Oxidase

2017

Other Studies

7 other study(ies) available for febuxostat and Kidney Failure, Chronic

ArticleYear
Kidney Transplant Outcomes in Patients With Adenine Phosphoribosyltransferase Deficiency.
    Transplantation, 2020, Volume: 104, Issue:10

    Topics: Adenine Phosphoribosyltransferase; Adolescent; Adult; Aged; Allopurinol; Enzyme Inhibitors; Europe; Febuxostat; Female; Graft Survival; Humans; India; Kidney Failure, Chronic; Kidney Transplantation; Male; Metabolism, Inborn Errors; Middle Aged; New South Wales; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; United States; Urolithiasis; Xanthine Oxidase; Young Adult

2020
Evaluation of the Effectiveness of Xanthine Oxidoreductase Inhibitors on Haemodialysis Patients using a Marginal Structural Model.
    Scientific reports, 2017, 10-25, Volume: 7, Issue:1

    Topics: Aged; Allopurinol; Cardiovascular Diseases; Enzyme Inhibitors; Febuxostat; Female; Gout Suppressants; Humans; Incidence; Kidney Failure, Chronic; Male; Models, Structural; Prognosis; Renal Dialysis; Risk Factors; Survival Rate; Uric Acid; Xanthine Dehydrogenase

2017
Successful treatment of refractory gout using combined therapy consisting of febuxostat and allopurinol in a patient with chronic renal failure.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:6

    Topics: Adrenal Cortex Hormones; Aged; Allopurinol; Arthritis, Gouty; Benzbromarone; Drug Therapy, Combination; Febuxostat; Gout Suppressants; Humans; Hyperuricemia; Kidney Failure, Chronic; Male; Thiazoles; Treatment Outcome; Xanthine Oxidase

2014
Febuxostat-associated rhabdomyolysis in chronic renal failure.
    The Medical journal of Australia, 2015, Jul-20, Volume: 203, Issue:2

    Topics: Aged; Febuxostat; Gout Suppressants; Humans; Kidney Failure, Chronic; Male; Rhabdomyolysis; Thiazoles

2015
Febuxostat in Hyperuricemic Patients With Advanced CKD.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2016, Volume: 68, Issue:5

    Topics: Adult; Aged; Febuxostat; Female; Gout Suppressants; Humans; Hyperuricemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Severity of Illness Index

2016
Febuxostat-induced agranulocytosis in an end-stage renal disease patient: A case report.
    Medicine, 2017, Volume: 96, Issue:2

    Topics: Aged; Agranulocytosis; Febuxostat; Female; Gout; Gout Suppressants; Humans; Kidney Failure, Chronic

2017
Effect of febuxostat on the progression of renal disease in 5/6 nephrectomy rats with and without hyperuricemia.
    Nephron. Physiology, 2008, Volume: 108, Issue:4

    Topics: Animals; Disease Models, Animal; Febuxostat; Hyperuricemia; Kidney; Kidney Failure, Chronic; Male; Microcirculation; Nephrectomy; Oxonic Acid; Rats; Rats, Wistar; Recovery of Function; Thiazoles; Treatment Outcome

2008